Allergy Providers | Alverno Laboratories

Spring is on the horizon, and with it comes a surge of allergy symptoms like wheezing, runny noses, and itchy eyes.

For patients with asthma, early testing is even more critical. The CDC and NIH recommend allergy testing for those with persistent asthma to help prevent worsening symptoms.^1,2

With 61% of U.S. patients going untested despite having allergy symptoms, it's more important than ever to utilize specific IgE blood testing right now to help uncover which allergens may cause symptoms in the coming months.³

This proactive approach ensures patients are prepared for the season ahead. Use lab code AGRS5 (Indiana) or AGRS9 (Illinois) to order our regional respiratory allergy profile and prepare your patients before the wheezing, sneezing, and itching get worse.

Determining whether the itchy eyes, runny nose, coughing, or sneezing is due to allergies or other non-allergic factors is crucial for effective treatment.

This is why it's vital that patients who have a history of symptoms be assessed for their allergen sensitizations with specific IgE testing.

Testing helps narrow your differential diagnosis, allowing for more confident and impactful treatment decisions. By ruling in or ruling out the role of allergens in patients' symptoms, you can avoid unnecessary treatments and focus on what truly affects your patients.

Use lab code AGRS5 (Indiana) or AGRS9 (Illinois) to order our regional respiratory allergy panel and optimize your diagnosis today.

It might not be just the pollen causing uncontrollable runny noses, sneezing, itchy eyes and more.

90% of patients with allergies are sensitized to multiple allergens and using specific IgE blood testing to help uncover what they are sensitized to can inform impactful management for reducing exposure wherever possible.⁵ For example, using dust mite covers, keeping the pet out of the bedroom, or cleaning mold in the bathroom are some simple exposure reduction ideas.

By knowing exactly which allergens are affecting a patient and using targeted exposure reduction to keep them below their allergy symptom threshold, patients may experience significant relief without the need to continuously use OTC antihistamines.

Order our regional respiratory specific IgE panel today with lab code AGRS5 (Indiana) or AGRS9 (Illinois) to help inform your patients targeted exposure reduction strategy and optimize the management of their symptoms more effectively.

References:

National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung, and Blood Institute. 2007.
Centers for Disease Control. https://www.cdc.gov/asthma/pdfs/AA_Fact_Sheet.pdf. Accessed 30 October 2024
Thermo Fisher Scientific, Summer 2022 US HCP Survey, fielded by Bioinformatics. N=230 US clinicians including allergists and primary care clinicians
Szeinbach SL, Williams B, Muntendam P, et al. Identification of allergic disease among users of antihistamines. J Manag Care Pharm. 2004;10(3):234-238
Ciprandi G, Alesina R, Ariano R, et al. Characteristics of patients with allergic polysensitization; the polismail study. Eur Ann Allergy Clin Immunol. 2008;40 (3);77-83.